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Background: Acute respiratory distress syndrome (ARDS) is characterized by the increased pulmonary permeability
secondary to diffuse alveolar inflammation and injuries of several origins. Especially, the distinction between a direct
(pulmonary injury) and an indirect (extrapulmonary injury) lung injury etiology is gaining more attention as a means
of better comprehending the pathophysiology of ARDS. However, there are few reports regarding the quantitative
methods distinguishing the degree of pulmonary permeability between ARDS patients due to pulmonary injury
and extrapulmonary injury.
Methods: A prospective, observational, multi-institutional study was performed in 23 intensive care units of
academic tertiary referral hospitals throughout Japan. During a 2-year period, all consecutive ARDS-diagnosed adult
patients requiring mechanical ventilation were collected in which three experts retrospectively determined the
pathophysiological mechanisms leading to ARDS. Patients were classified into two groups: patients with ARDS
triggered by extrapulmonary injury (ARDSexp) and those caused by pulmonary injury (ARDSp). The degree of
pulmonary permeability using the transpulmonary thermodilution technique was obtained during the first three
intensive care unit (ICU) days.
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Results: In total, 173 patients were assessed including 56 ARDSexp patients and 117 ARDSp patients. Although the
Sequential Organ Failure Assessment (SOFA) score was significantly higher in the ARDSexp group than in the
ARDSp group, measurements of the pulmonary vascular permeability index (PVPI) were significantly elevated in the
ARDSp group on all days: at day 0 (2.9 ± 1.3 of ARDSexp vs. 3.3 ± 1.3 of ARDSp, p = .008), at day 1 (2.8 ± 1.5 of
ARDSexp vs. 3.2 ± 1.2 of ARDSp, p = .01), at day 2 (2.4 ± 1.0 of ARDSexp vs. 2.9 ± 1.3 of ARDSp, p = .01). There were
no significant differences in mortality at 28 days, mechanical ventilation days, and hospital length of stay between
the two groups.
Conclusions: The results of this study suggest the existence of several differences in the increased degree of
pulmonary permeability between patients with ARDSexp and ARDSp.
Trial registration: This report is a sub-group analysis of the study registered with UMIN-CTR (ID UMIN000003627).
Keywords: Acute pulmonary edema, Acute respiratory distress syndrome, Indirect injury, Direct injury, Pulmonary
vascular permeability, Transpulmonary thermodilution techniqueBackground
Acute respiratory distress syndrome (ARDS) is a challen-
ging disease renowned to any intensive care unit (ICU)
and is associated with a high mortality rate, as docu-
mented by recent systematic reviews finding a pooled
mortality of 44% and 43% [1,2].
ARDS is characterized by the increased pulmonary ca-
pillary permeability secondary to diffuse alveolar inflam-
mation and injuries [3]. Common risk factors can be
classified into two groups: extrapulmonary causes (indir-
ect etiologies: ARDSexp) or pulmonary causes (direct
etiologies: ARDSp). The major causes of ARDSexp in-
clude non-pulmonary sepsis, major trauma, pancreatitis,
severe burns, non-cardiogenic shock, drug overdose, and
multiple transfusions, while the main causes of ARDSp
are pneumonia, aspiration of gastric contents, inhalation
injury, pulmonary contusion, pulmonary vasculitis, and
drowning [4]. Lung injuries of different origins may hold
distinct pathophysiology, lung morphology, radiology,
respiratory mechanics, and response to managements
[5]. This distinction between an indirect and a direct eti-
ology of lung injury is gaining more attention as a means
of better comprehending the pathophysiology of ARDS
and possibly for modifying ventilator management [6,7].
Several studies have reported the difference between re-
spiratory mechanics and severity between ARDSexp and
ARDSp [6-8]. Gattinoni et al. [6] measured the elastic
properties of the lung and chest wall by using the quasi-
static technique and reported that the differences in
respiratory mechanics and response to positive end-
expiratory pressure (PEEP) between patients with ARD-
Sexp and those with ARDSp were predominantly due to
collapse. On the other hand, a systematic review consist-
ing of 34 studies exhibited no difference in mortality be-
tween both groups [9]. Presently, we believe that
radiological imaging, respiratory mechanics, as well as
response to PEEP features between both groups do notaffect mortality. We consider that no difference in mor-
tality between both groups may depend on the same
therapeutic strategy given to all ARDS cases. ARDS pa-
tient outcomes may be improved with specific modified
therapies that would address the underlying pathologies
during the initial stage. We believe that more quantita-
tive methods estimating the heterogeneity of ARDS at
the initial stage and a customized therapy for each indi-
vidual case may be helpful to appropriately manage
ARDS patients.
There are few quantitative methods that distinguish
between both ARDS categories during their initial stages.
As ARDS is a syndrome and includes various clinical
conditions, the absolute difference between ARDSexp
and ARDSp is still unknown. We hypothesized that the
degree of increased pulmonary permeability caused by
several underlying diseases may be different between pa-
tients within the two ARDS categories. We set out to de-
termine whether there were any differences between the
two groups in terms of the degree of pulmonary edema
during the initial ICU stages.
The transpulmonary thermodilution technique system
(PiCCO®, Pulsion Medical Systems, Munich, Germany)
is able to establish the degree of pulmonary vascular per-
meability with the pulmonary vascular permeability
index (PVPI) [10]. Kirov et al. [11] reported that the
value of PVPI was high in a sheep model with ARDS.
Furthermore, a clinical study by Monnet et al. [12]
showed that PVPI was higher in patients with ARDS
than in those with cardiogenic pulmonary edema. These
results suggest that PVPI seemed to be useful to esti-
mate the difference in pulmonary vascular permeability
between the types of pulmonary edema [13]. We previ-
ously reported that PVPI was significantly higher in
ARDS patients than in patients who had cardiogenic
pulmonary edema despite both having diffuse bilateral in-
filtrates of the lung and hypoxemia. A PVPI of 2.6–2.85
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ARDS with permeability edema from cardiogenic edema
or atelectasis which could lead to clinical symptoms that
mimic ARDS [14]. Therefore, PVPI might reflect the var-
iety of difference of causes that lead to ARDS.
To our knowledge, little data regarding the difference
of PVPI elevation between ARDSexp and ARDSp in the
ICU setting is available. The aim of this study was to
evaluate the difference in pulmonary vascular permeabil-
ity, using the value of PVPI between patients with ARD-
Sexp and those with ARDSp.
Methods
We undertook a prospective, observational, multi-institutional
study from March 2009 to August 2011. Patients admitted
to the ICU of 23 hospitals in different regions of Japan
were screened for ARDS as a sub-analysis of a clinical
observational study utilizing hemodynamic monitoring
with PiCCO® [14]. The study was approved by the institu-
tional ethics committee, and written informed consent was
obtained from all study participants. This study was also
registered with the University Hospital Medical Informa-
tion Network (UMIN) Clinical Trials Registry (UMIN-
CTR ID UMIN000003627).
We assessed medical and surgical patients according
to the following five criteria: (1) older than 15 years of
age (no upper age limit), (2) acute respiratory insuffi-
ciency expected to require mechanical ventilatory sup-
port in ICU for at least 48 h, (3) PaO2/FiO2 (P/F) ratio
of ≤300 mmHg, (4) bilateral infiltrates on chest radio-
graph, (5) monitoring by the transpulmonary thermodi-
lution technique as per the discretion of attending
physicians. Patients were excluded if one of the following
criteria was present: definition of ARDS over 5 days
prior to eligibility; past history of chronic respiratory in-
sufficiency (mainly, chronic obstructive pulmonary dis-
ease); post lung resection/pneumonectomy; pulmonary
thromboembolism; severe peripheral arterial disease;
cardiogenic shock (cardiac index <1.5 L/min/m2); acute
phase of trauma with lung contusion, drowning, and
burns; unsuitable situation for monitoring with PiCCO®.
Three or more experts (intensive care, respiratory, and
cardiology) determined the diagnosis of ARDS taking
into account medical history, clinical features involving
computed tomography (CT) appearances, respiratory
and hemodynamic variables, and clinical course with
therapy. We excluded all cases of respiratory failure that
were caused by massive pneumothorax, atelectasis, and
pleural effusion. Any case with an extravascular lung
water index (EVLWI) <10 mL/kg was excluded [14].
The following data were collected from the medical re-
cords: age, gender, underlying disease, hospital length of
stay, length of mechanical ventilation, and clinical out-
come at 28 days (survival or death). We also calculatedthe Acute Physiology and Chronic Health Evaluation
(APACHE) II score, Sequential Organ Failure Assess-
ment (SOFA) score, PEEP, and P/F ratio at day 0. Once
the above-mentioned criteria were fulfilled, we com-
menced PiCCO® measurement data collection in which
all patients were monitored for three consecutive days:
day 0, day 1, and day 2. PVPI and extravascular lung
water (EVLW) were measured concurrently. At the same
time, intrathoracic blood volume (ITBV) was measured
as volumetric parameters by PiCCO®. We calculated
EVLWI with predicted body weight and intrathoracic
blood volume index (ITBI) with area of body surface.
We utilized predicted body weight to index EVLW and
ITBV according to previous studies which determined
that EVLWI indexed to the predictive body weight was a
better prognostic indicator for ARDS patients than
EVLWI indexed to the actual body weight [15,16].
From the various diagnosed causes of ARDS, we classi-
fied all patients into two groups (indirect injury group or
direct injury group). We assessed each patient's medical
history, clinical presentation, chest CT, radiography, and
echocardiography. Indirect injury group (ARDSexp) in-
cluded patients with ARDS secondary to non-pulmonary
sepsis, major trauma, pancreatitis, severe burns, non-
cardiogenic shock, drug overdose, and multiple transfu-
sions. The direct injury group (ARDSp) included patients
with ARDS caused by pneumonia, aspiration of gastric
contents, inhalation injury, pulmonary contusion, pul-
monary vasculitis, and drowning [4]. Patients that pre-
sented with acute phase of inhalation burn, pulmonary
contusion, and drowning were excluded from the study.
All the experts who conducted the classification were
blinded to the value of PVPI.
Statistical analysis
Descriptive frequencies were expressed using the mean
and standard deviation (SD). Categorical data was ana-
lyzed using Pearson's chi-square test for the characteris-
tics and 28-day mortality. The independent t test was
used for normally distributed variables, or the Mann–
Whitney U test was used for non-normally distributed
variables. All tests were two-sided, and p < .05 was con-
sidered to be significant. We analyzed all data using
SPSS software, version 18 for Windows (SPSS, Chicago,
IL, USA).
Results
During the study period from March 2009 to August
2011, we assessed a total of 301 patients that were sub-
jected to mechanical ventilation. Of these, 94 were ex-
cluded due to reasons presented in Figure 1. Of the
remaining 207 cases with absolute ARDS, the experts
categorized 34 patients as neither ARDSexp nor ARDSp
groups due to lack of a clear identification of the









34 patients were classified neither ARDSexp nor ARDSp
35 patients excluded 
EVLWI <10ml/kg (n = 14)
unclassified by expert decision (n = 8)
atelectasis and consolidation due to pneumonia (n = 5)
acute phase of inhalation burn and lung contusion (n = 3)
non-acute onset (n = 2)
acute phase of drowning (n = 1)
combined with chronic obstructive pulmonary disease (n = 1)





173 final study samples
Figure 1 Patient flow diagram.
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disease. The remaining 173 patients were included into
the final analysis.
Patients' characteristics are summarized in Table 1. Of
these, the age range of affected patients was 21–93 years
(median 67 years), with 67% males. Fifty-six patients (32%)
had a diagnosis of ARDSexp, and 117 patients (68%) had a
diagnosis of ARDSp. The most common cause of ARD-
Sexp was sepsis (71%) and pneumonia (80%) in ARDSp.
Significant differences in baseline characteristics were
seen between the two groups with the SOFA score
(ARDSexp 12 ± 4 vs. ARDSp 10 ± 3; p = .0001) and the
concentration of serum albumin (2.4 g/dL of ARDSexp
vs. 2.7 g/dL of ARDSp; p = .02). There were no signifi-
cant differences in APACHE II, PEEP, and mean airway
pressure initially. The P/F ratio tended to be lower in
ARDSp than ARDSexp (163 ± 73 of ARDSexp vs. 143 ±
70 of ARDSp; p = .09).
Results of measurements of PiCCO® at day 0, day 1,
and day 2 are summarized in Table 2. The measurement
of PVPI (Figure 2) was significantly elevated in ARDSp
compared with ARDSexp on all days: at day 0 (2.9 ± 1.3
of ARDSexp vs. 3.3 ± 1.3 of ARDSp, p = .008), at day 1
(2.8 ± 1.5 of ARDSexp vs. 3.2 ± 1.2 of ARDSp, p = .01), at
day 2 (2.4 ± 1.0 of ARDSexp vs. 2.9 ± 1.3 of ARDSp,
p = .01). All ITBI data from both groups was in the upper
range of normal. Although there was no significantdifference in the EVLWI at day 0 and day 1, the level of
EVLWI in the ARDSp group was significantly higher
than that in the ARDSexp patients at day 2 (14.9 ± 6.0 of
ARDSexp vs. 17.6 ± 7.8 of ARDSp, p = .02).
Patients' outcomes are summarized in Table 3. There
was no significant difference in 28-day mortality, hos-
pital stay days, and ventilation days between the two
groups as follows: mechanical ventilation (16 ± 19 days
of ARDSexp vs. 13 ± 9 days of ARDSp, p = .85), hospital
length of stay (42 ± 55 days of ARDSexp vs. 40 ± 56 days
of ARDSp, p = .51), and mortality at 28 days (32% of
ARDSexp vs. 44% of ARDSp, p = .15).
Discussion
ARDS is considered to be an expression of a diffuse in-
flammatory reaction within the lungs caused by a num-
ber of underlying diseases, which have a variety of
pathophysiological courses being either of pulmonary or
extrapulmonary origin. Thus, depending on its etiology,
ARDS may present with obvious distinct characteristics.
In this study, we attempted to establish the quantitative
difference in pulmonary permeability between ARDSexp
and ARDSp with PVPI obtained by the transpulmonary
thermodilution technique (PiCCO®).
The characteristics and clinical outcomes in both
groups were similar to previous studies [6,8,17,18]. The
prevalence of ARDSp in this study was higher compared
Table 1 Characteristics of 173 patients at the initial
measurement of thermodilution technique
ARDSexp ARDSp p value
n = 56 n = 117
Age (year), median 65 72 .03
Male, n (%) 32 (57) 84 (72) .05
Causes of ARDS, n (%)
Sepsis 40 (71)





Lung contusion 2 (2)
Inhalation burn 1 (1)
APACHE II score 24 ± 9 23 ± 8 .39
SOFA score 12 ± 4 10 ± 3 .0001
PEEP (cmH2O) 9 ± 5 9 ± 5 .36
PaO2/FiO2 ratio 163 ± 73 143 ± 70 .09
Mean airway pressure (cmH2O) 17 ± 6 17 ± 4 .55
Na (mmol/L) 135 ± 19 138 ± 7 .37
K (mmol/L) 4.1 ± 0.8 4.0 ± 0.9 .15
Albumin (g/dL) 2.4 ± 0.5 2.6 ± 0.8 .02
Glucose (mg/dL) 159 ± 61 165 ± 83 .95
Blood urea nitrogen (mg/dL) 38 ± 28 36 ± 25 .84
Values are given as mean ± standard deviation, unless otherwise indicated.
ARDS acute respiratory distress syndrome, ARDSexp acute respiratory distress
syndrome secondary to extrapulmonary cause, ARDSp acute respiratory
distress syndrome secondary to pulmonary cause, TRALI transfusion-related
acute lung injury, APACHE Acute Physiologic and Chronic Health Evaluation,
SOFA Sequential Organ Failure Assessment, PEEP positive
end-expiratory pressure.
Table 2 Results of the measurement by thermodilution
technique
ARDSexp ARDSp p value
n = 56 n = 117
Day 0
ITBI 1,067 ± 236 1,015 ± 270 .09
EVLWI 17.8 ± 6.6 19.0 ± 7.1 .20
PVPI 2.9 ± 1.3 3.3 ± 1.3 .008
Day 1
ITBI 1,069 ± 309 1,019 ± 279 .37
EVLWI 17.0 ± 8.0 18.0 ± 7.0 .16
PVPI 2.8 ± 1.5 3.2 ± 1.2 .01
Day 2
ITBI 1,095 ± 263 1,078 ± 313 .41
EVLWI 14.9 ± 6.0 17.6 ± 7.8 .02
PVPI 2.4 ± 1.0 2.9 ± 1.3 .01
Values are given as mean ± standard deviation. ARDSexp acute respiratory
distress syndrome secondary to extrapulmonary cause, ARDSp acute
respiratory distress syndrome secondary to pulmonary cause, ITBI intrathoracic
blood volume index, EVLWI extravascular lung water index, PVPI pulmonary
vascular permeability index.
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patients with sepsis and trauma, as opposed to ARDSp
which consisted of those with pneumonia and aspiration
[6,8,17,18]. Although these various clinical backgrounds
may influence ARDS outcomes, no significant differ-
ences in 28-day mortality, length of hospital stay, and
number of mechanical ventilation days were noted be-
tween the ARDSexp or ARDSp patients in this study.
These results concur with a previously reported meta-
analysis which manifested no difference in mortality be-
tween ARDSexp and ARDSp [9]. Agarwal et al. [8] also
reported that categories of underlying disease did not
affect the duration of hospitalization and the number of
mechanical ventilation days, although this study showed
that the initial severity of respiratory failure, PaO2/FiO2
ratio, was worse in patients with ARDSp than in those
with ARDSexp. Each of the two ARDS groups character-
ized by different origins arguably has a different patho-
physiological course for the lung permeability along withsimilar clinical syndromes and outcomes. Hence, the ini-
tial separation of ARDSexp and ARDSp appears to be
futile for predicting outcome from ARDS.
The value of ITBI as volumetric parameters by PiCCO®
in both groups was in the upper normal range. All partici-
pants were managed with appropriate fluid therapy during
their admission to ICU. On the other hand, the value of
PVPI was extremely elevated above the normal range
(PVPI of 2.6–2.85; differential value to diagnose real
ARDS [14]). We believe that these results suggest that all
the included cases demonstrated permeability pulmonary
edema, namely real ARDS with no cases of cardiogenic
pulmonary edema or fluid overload which could be one
of the most important biases to assess permeability pul-
monary edema.
Patients with ARDSexp had significantly higher SOFA
scores and lower albumin concentrations similarly to the
report by Agarwal et al. [8]. We found PVPI in the ARD-
Sexp group to be lower than that in those with ARDSp
and speculate that the direct insult (i.e., caused by pul-
monary infection, aspiration, and trauma) may have in-
fluenced the pulmonary permeability to a greater extent
than the indirect insult with systematic hyper-cytokine
storm caused by sepsis. We also noted EVLWI in the
ARDSexp group to be lower than that in the ARDSp
group. Generally, lower albumin concentrations lead to
lower osmotic pressure, so that patients with hypoalbu-
minemia suffer from whole body edema, ascites, and
especially pericardial effusion. Nevertheless, we found
that direct insult caused the increase of EVLWI greater
than systematic inflammation and hypoalbuminemia.











Figure 2 Comparison of PVPI between ARDSexp and ARDSp during the study period. The measurement of PVPI was significantly elevated
in ARDSp compared with ARDSexp on all days: at day 0 (2.9 ± 1.3 of ARDSexp vs. 3.3 ± 1.3 of ARDSp, p = .008), at day 1 (2.8 ± 1.5 of ARDSexp vs.
3.2 ± 1.2 of ARDSp, p = .01), at day 2 (2.4 ± 1.0 of ARDSexp vs. 2.9 ± 1.3 of ARDSp, p = .01).
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compared the response of pulmonary epithelium damage
caused by intraperitoneally or intratracheally exposed lipo-
polysaccharide and which concluded that the intratracheal
insult leads to greater lung inflammation and ultrastruc-
tural morphologic changes. The levels of inflammatory cy-
tokines (interleukin-6, interleukin-8 function homolog, and
interleukin-10) found in the bronchoalveolar lavage fluid
were significantly elevated in pulmonary ARDS models
compared to extrapulmonary ARDS models, whereas no
differences were observed in the number of infiltrating
neutrophils [19]. This suggests, therefore, that the level of
inflammation and the activation of neutrophils in patients
with ARDSp may be higher than those in patients with
ARDSexp.
There are several limitations to this study. First, the
sample size was relatively small due to strict exclusion
criteria to omit cases with complications that might also
lead to hypoxemia and bilateral infiltrate on chest X-ray,
including massive pneumothorax, atelectasis, and pleural
effusion, to ensure that we included real ARDS patients.Table 3 Clinical outcomes for participants
ARDSexp ARDSp p value
n = 56 n = 117
28-day mortality, n (%) 18 (32) 51 (44) .15
Hospital stay days 42 ± 55 40 ± 56 .51
Ventilation days 16 ± 19 13 ± 9 .85
Values are given as mean ± standard deviation, unless otherwise indicated.Second, the numbers of ARDSexp were fewer than those
of ARDSp (56 of ARDSexp vs. 117 of ARDSp). There
might be some statistical bias. We also excluded 94 cases
with acute respiratory failure resulting from cardiogenic
pulmonary edema, plural effusion, and atelectasis that
might resemble ARDS (i.e., hypoxia with diffuse bilateral
infiltrates) despite the lack of increased pulmonary per-
meability. We are concerned that our strict exclusion
criteria may have excluded those with severe respiratory
failure, and participants were limited to more moderate
cases. However, we believe that our exclusion criteria
provided an appropriate estimate of the key features of
ARDS, namely participants with increased pulmonary
permeability edema. We also excluded cases suspected
of having both etiologies (ARDSexp and ARDSp) from
our analysis. Finally, the varied and complicated factors
of the underlying disease might influence the accuracy
of thermodilution technique measurements. For this
matter, we did not compare all those factors that could
affect the accuracy of PiCCO® findings but rather only
the cases that were deemed possible of adequate PiCCO®
monitoring.
To our knowledge, there are few reports considering
quantitative methods distinguishing both types of ARDS
within the ICU setting. In a clinical situation, timely rec-
ognition of the difference and course in an ARDS lung is
essential to drive and inform the clinical decision pro-
cesses and dictate specific therapeutic strategies. The
quantitative differences in EVLWI and PVPI obtained by
the PiCCO® system may be one important index that
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and ARDSp by estimating the amount of pulmonary per-
meability. Monitoring with PiCCO® might give us timely
quantitative information to make more informed clinical
decisions.
Conclusions
The results of this study suggest that the PiCCO® monitor-
ing could be useful to distinguish between the state of pul-
monary permeability in ARDSexp and ARDSp patients.
We believe that there is a fundamental difference in the
pathophysiology between these ARDSexp and ARDSp
groups. Utilizing PVPI may provide us with timely quanti-
tative information of pulmonary permeability in these two
forms of ARDS. Additional studies should be undertaken
in order to determine whether the clinical strategy guided
with PVPI can have an impact on outcome and improve
hypoxemia for patients with ARDS.
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